US Broker Ratings

Cytokinetics, Incorporated (CYTK) Stock Analysis: Evaluating a Potential 43% Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK) presents a compelling case for investors with its focus on pioneering muscle activators and inhibitors aimed at treating debilitating diseases. Despite recent..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Biotechnology Innovator Seeks 28.67% Upside with Breakthrough Therapies

Rhythm Pharmaceuticals, Inc. (RYTM), a trailblazer in the biotechnology sector, is garnering attention for its innovative approaches to treating rare neuroendocrine diseases. With a market capitalization..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Upside Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a stalwart in the healthcare sector, specifically within the medical devices industry, with a robust presence across the United States..

BrightSpring Health Services, I (BTSG): Investor Outlook with a 34% Potential Upside

BrightSpring Health Services, Inc. (NYSE: BTSG) is making waves in the healthcare sector, particularly in the health information services industry. With a substantial market cap of..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Star with 125.70% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its innovative approach to cell therapies, particularly in oncology. This U.S.-headquartered company, founded..

Glaukos Corporation (GKOS) Investor Outlook: Strong Buy Ratings and Impressive Revenue Growth Set the Stage

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in ophthalmic pharmaceuticals and medical technology, has caught the attention of investors with its..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 9.88% Potential Upside for Investors

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $5.88..

Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), known for its expansive portfolio of over-the-counter health and personal care products, presents a compelling opportunity for investors seeking growth..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Biotech Innovator with a 15.20% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the biotechnology sector with its innovative approach to drug development and strategic focus on unmet medical needs. While..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential with a Robust 36.29% ROE

TransMedics Group, Inc. (TMDX) is paving its path in the healthcare sector as a groundbreaking player in the medical devices industry. As a commercial-stage medical technology..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Robust Pipeline Drive Investor Interest

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative enzyme-based drug delivery solutions. With a market capitalization of $12.28 billion,..

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Analyzing a 37% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC), a market leader in the digital healthcare space, is capturing investor attention with its promising 37% potential upside. With its cutting-edge..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Promising 20.90% Upside in Healthcare Diagnostics

RadNet, Inc. (NASDAQ: RDNT) is an intriguing entity within the healthcare sector, specifically in the Diagnostics & Research industry. With a substantial market capitalization of $6.05..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Sector with Caution

For investors with a keen eye on the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) presents a unique blend of strategic positioning and cautious optimism. As..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Player with a Potential 89% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) is garnering attention in the biotechnology sector, primarily due to its focus on RNA therapeutics aimed at transforming cardiac care. With..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Discovering a 11% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company, is drawing significant attention from the investment community. With a market capitalization of $10.26 billion, this healthcare..

Medtronic plc (MDT) Investor Outlook: A Healthcare Giant with a Promising Upside

Medtronic plc (NYSE: MDT) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Galway, Ireland, Medtronic’s..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomics Giant’s 9.40% Revenue Growth amid Volatility

Illumina, Inc. (NASDAQ: ILMN) has positioned itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego,..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 70% Revenue Growth in Healthcare

Oscar Health, Inc. (NYSE: OSCR) has become a noteworthy player in the healthcare sector, standing out in the healthcare plans industry with an impressive market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Growth Potential with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of precision oncology, providing innovative blood and tissue tests that are reshaping the landscape of cancer diagnostics...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds